Neuromodulation: Technology at the Neural Interface This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

First Evaluation Switching From Ropivacaine to Highly Concentrated Bupivacaine in Intrathecal Mixtures for Cancer Pain
ConclusionSwitching from ropivacaine to bupivacaine in IDDS appears more efficacious while remaining just as secure, and at lower cost. (Source: Neuromodulation: Technology at the Neural Interface)
Source: Neuromodulation: Technology at the Neural Interface - June 29, 2021 Category: Biotechnology Authors: Florent Bienfait, Sabrina Jubier ‐Hamon, Valérie Seegers, Yves‐Marie Pluchon, Nathalie Lebrec, Virginie Jaoul, François Boré, Thierry Delorme, Julien Robert, Martine Bellanger, Jérémy Sorrieul, Denis Dupoiron Tags: Clinical Research Source Type: research

Transcutaneous Auricular Vagus Nerve Stimulation Combined With Slow Breathing: Speculations on Potential Applications and Technical Considerations
ConclusionsCombining taVNS with slow breathing seems to be a promising hybrid neurostimulation and behavioral intervention. (Source: Neuromodulation: Technology at the Neural Interface)
Source: Neuromodulation: Technology at the Neural Interface - June 23, 2021 Category: Biotechnology Authors: Miko łaj Tytus Szulczewski Tags: Review Article Source Type: research

A Review of Neuromodulation for Treatment of Complex Regional Pain Syndrome in Pediatric Patients and Novel Use of Dorsal Root Ganglion Stimulation in an Adolescent Patient With 30 ‐Month Follow‐Up
ConclusionsDRG stimulation has been shown to significantly alter the symptomatology in patients with CRPS. This case suggests that DRG stimulation may be as effective for the treatment of refractory CRPS in pediatric patients as in adults. (Source: Neuromodulation: Technology at the Neural Interface)
Source: Neuromodulation: Technology at the Neural Interface - June 23, 2021 Category: Biotechnology Authors: Heather Pinckard ‐Dover, Angela Palmer, Erika A. Petersen Tags: Review Article Source Type: research

The Pathways and Processes Underlying Spinal Transmission of Low Back Pain: Observations From Dorsal Root Ganglion Stimulation Treatment
BackgroundDorsal root ganglion stimulation (DRG-S) is a novel approach to treat chronic pain. Lead placement at L2 has been reported to be an effective treatment for axial low back pain (LBP) primarily of discogenic etiology. We have recently shown, in a diverse cohort including cases of multilevel instrumentation following extensive prior back surgeries, that DRG-S lead placement at T12 is another promising target. Local effects at the T12 DRG, alone, are insufficient to explain these results.Materials and MethodsWe performed a literature review to explore the mechanisms of LBP relief with T12 DRG-S.FindingsBranches of in...
Source: Neuromodulation: Technology at the Neural Interface - June 23, 2021 Category: Biotechnology Authors: Kenneth B. Chapman, Pauline S. Groenen, Kris C. Vissers, Noud Helmond, Michael D. Stanton ‐Hicks Tags: Review Article Source Type: research

Calendar of Events
(Source: Neuromodulation: Technology at the Neural Interface)
Source: Neuromodulation: Technology at the Neural Interface - June 23, 2021 Category: Biotechnology Tags: Professional Development Source Type: research

Table of Contents
(Source: Neuromodulation: Technology at the Neural Interface)
Source: Neuromodulation: Technology at the Neural Interface - June 23, 2021 Category: Biotechnology Tags: Issue Information – Table of Contents Source Type: research

Aims and Scope
(Source: Neuromodulation: Technology at the Neural Interface)
Source: Neuromodulation: Technology at the Neural Interface - June 23, 2021 Category: Biotechnology Tags: Issue Information – Aims and Scope Source Type: research

Editorial Board
(Source: Neuromodulation: Technology at the Neural Interface)
Source: Neuromodulation: Technology at the Neural Interface - June 23, 2021 Category: Biotechnology Tags: Issue Information – Editorial Board Source Type: research

Dr. Jan Holsheimer 1941 –2021
(Source: Neuromodulation: Technology at the Neural Interface)
Source: Neuromodulation: Technology at the Neural Interface - June 23, 2021 Category: Biotechnology Authors: Mathieu W.P.M. Lenders, Kuan H. Kho, Cecile C. Vos, Andr é Elands Tags: Obituary Source Type: research

Abstracts from the North American Neuromodulation Society's 2021 Virtual Meeting, January 15 –16, 2021
(Source: Neuromodulation: Technology at the Neural Interface)
Source: Neuromodulation: Technology at the Neural Interface - June 23, 2021 Category: Biotechnology Tags: Abstracts Source Type: research

Dorsal Root Ganglion Stimulation for Post ‐Lyme Disease Chronic Peripheral Neuropathic Pain
(Source: Neuromodulation: Technology at the Neural Interface)
Source: Neuromodulation: Technology at the Neural Interface - June 23, 2021 Category: Biotechnology Authors: Jay Karri, Brian Bruel Tags: Letter to the Editor Source Type: research

Remembrances for a Departed Colleague, Friend, and Mentor: Jan Holsheimer, PhD
(Source: Neuromodulation: Technology at the Neural Interface)
Source: Neuromodulation: Technology at the Neural Interface - June 23, 2021 Category: Biotechnology Tags: Letter to the Editor Source Type: research

Response to: “Adverse Events and Complications Associated With Intrathecal Drug Delivery Systems: Insights From the Manufacturer and User Facility Device Experience (MAUDE) Database”
(Source: Neuromodulation: Technology at the Neural Interface)
Source: Neuromodulation: Technology at the Neural Interface - June 23, 2021 Category: Biotechnology Authors: David Schultz, Alaa Abd ‐Elsayed Tags: Letter to the Editor Source Type: research

“Response to Letter to the Editor Regarding: Managing Intrathecal Drug Delivery Devices in a Global Pandemic”: A Correction
(Source: Neuromodulation: Technology at the Neural Interface)
Source: Neuromodulation: Technology at the Neural Interface - June 23, 2021 Category: Biotechnology Authors: Andrew Purcell, David M. Moore Tags: Letter to the Editor Source Type: research

Response to Letter to the Editor Regarding: “Adverse Events and Complications Associated With Intrathecal Drug Delivery Systems: Insights From the Manufacturer and User Facility Device Experience (MAUDE) Database”
(Source: Neuromodulation: Technology at the Neural Interface)
Source: Neuromodulation: Technology at the Neural Interface - June 23, 2021 Category: Biotechnology Authors: Vasudha Goel, Hariharan Shankar Tags: Letter to the Editor Source Type: research